EssexBio

Essex-Bio Group

简繁 EN

ANNOUNCEMENTS & SHAREHOLDER INFORMATION

Normative Disclosure, Honest Communication

Date

Title

File

Times

2021-08-04

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2021

1526

2021-07-29

NOTICE OF BOARD MEETING

1728

2021-07-20

POSITIVE PROFIT ALERT

1632

2021-07-19

VOLUNTARY ANNOUNCEMENT FIRST PATIENT FIRST VISIT COMPLETED IN THE PRC IN RELATION TO THE CO-DEVELOPMENT OF THE LICENSED PRODUCT WITH HENLIUS RELATING TO THE TREATMENT OF EXUDATIVE (WET) AGE-RELATED MACULAR DEGENERATION

1649

2021-07-06

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2021

1588

2021-06-28

NEXT DAY DISCLOSURE RETURN

1694

2021-06-09

DISCLOSEABLE TRANSACTION PRODUCT INTERESTS TRANSFER AGREEMENT RELATING TO IODIZED LECITHIN CAPSULES

1900

2021-06-02

NEXT DAY DISCLOSURE RETURN

1676

2021-06-02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2021

1655

2021-05-28

NEXT DAY DISCLOSURE RETURN

1732

2021-05-24

NEXT DAY DISCLOSURE RETURN

1711

2021-05-21

NEXT DAY DISCLOSURE RETURN

1591

2021-05-17

VOLUNTARY ANNOUNCEMENT UNAUDITED OPERATING STATISTICS FOR THE FOUR MONTHS ENDED 30 APRIL 2021

1653

2021-05-12

POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 12 MAY 2021

1559

2021-05-04

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2021

1651

2021-04-30

NEXT DAY DISCLOSURE RETURN

1904

2021-04-20

VOLUNTARY ANNOUNCEMENT FURTHER UPDATE IN RELATION TO THE CO-DEVELOPMENT OF THE LICENSED PRODUCT WITH HENLIUS RELATING TO THE TREATMENT OF EXUDATIVE (WET) AGE-RELATED MACULAR DEGENERATION

1883

2021-04-19

NEXT DAY DISCLOSURE RETURN

1887

2021-04-12

NEXT DAY DISCLOSURE RETURN

1894

2021-04-07

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2021

1642

This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.

ACCEPT